MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Impact of prolonged temporal discrimination threshold on finger movements of Parkinson’s disease

    M.J. Lee, J.S. Son, J.H. Lee, S.J. Kim, C.H. Lyoo, M.S. Lee (Busan, Korea)

    Objective: In present study, we investigated the impact of temporal discrimination threshold (TDT) prolongation on simple repetitive finger tapping and dexterous finger movement in patients…
  • 2016 International Congress

    Multidisciplinary group program integrating voice and dance movement therapy for Parkinson’s disease patients: Preliminary experience

    R. Peled, D. Shpunt, Y. Manor, M. Brozgol, A. Ezra, N. Hezi, R. Hen Simon, J.M. Hausdorff, T. Gurevich (Tel Aviv, Israel)

    Objective: To examine the effects of “Voice in Motion“ group therapy on movement, speech and QOL of PD patients. Background: Physical exercise and speech therapy…
  • 2016 International Congress

    Dissecting the molecular mechanisms of Fyn-mediated levodopa induced dyskinesias

    M.P. Bordone, M.A. Bernardi, A. Damianich, S. Sanz-Blasco, G. Gómez, I.R.E. Taravini, M.E. Avale, O.S. Gershanik, J.E. Ferrario (Buenos Aires, Argentina)

    Objective: To investigate the crosstalk between D1 receptor (D1R) and the signaling of Fyn protein kinase in a mice model of levodopa (L-DOPA) induced dyskinesias…
  • 2016 International Congress

    Olfaction and gray matter volume in Parkinson’s disease. A voxel-based morphometry study

    K. Witt, N. Schmidt, O. Granert, L. Paschen, S. Wolff, G. Deuschl (Kiel, Germany)

    Objective: To evaluate the relation between olfactory functioning and gray matter (GM) volume in patients with Parkinson's disease (PD). Background: Olfactory impairment is one of…
  • 2016 International Congress

    Cellular senescence induced by paraquat drives neuropathology associated with Parkinson’s disease

    S.J. Chinta, G. Woods, M. Demaria, J. Campisi, J.K. Andersen (Novato, CA, USA)

    Objective: To understand the role of cellular senescence in brain aging and neurodegeneration in Parkinson's disease models. Background: Although cellular senescence has been causally linked…
  • 2016 International Congress

    Urate and homocysteine: Changes in motor and cognitive symptoms in newly diagnosed Parkinson’s disease

    I.J. Sleeman, R. Lawson, A. Yarnall, G. Duncan, F. Johnston, T. Khoo, D. Collerton, J.P. Taylor, D. Burn (Newcastle upon Tyne, United Kingdom)

    Objective: 1) To determine serum urate and homocysteine concentration at baseline, 18 and 36 months in control and PD participants. 2) To determine if urate…
  • 2016 International Congress

    Dysregulated macroautophagy and mitochondrial dynamics in PD with glucocerebrosidase mutations

    S.H. Kuo, H. Li, A. Ham, M.M. Cheng, Y. Quan, D. Sulzer, G. Tang (New York, NY, USA)

    Objective: To investigate markers of macroautophagy and mitochondrial dynamics in fibroblasts and postmortem brain of Parkinson's disease (PD) patients with glucoerebrosidase (GBA1) mutations and controls.…
  • 2016 International Congress

    Mitochondrial-nuclear interplay in single respiratory chain-deficient Parkinson’s disease neurons

    A. Grünewald, K.A. Rygiel, P.D. Hepplewhite, C.M. Morris, M. Picard, D.M. Turnbull (Belvaux, Luxembourg)

    Objective: To explore the role of the mitochondrial DNA (mtDNA) in the development of respiratory chain complex (CI-IV) deficiencies in the substantia nigra (SN) of…
  • 2016 International Congress

    Kinematic analysis of repetitive finger movements and the effects of selegiline and pramipexole in early Parkinson’s disease

    G. Leodori, M. Bologna, P. Stirpe, G. Paparella, D. Belvisi, A. Fasano, G. Fabbrini, A. Berardelli (Rome, Italy)

    Objective: To characterize the features of bradykinesia in newly diagnosed patients with Parkinson's disease (PD) and the response to pramipexole and selegiline administration. Background: Motor…
  • 2016 International Congress

    LC3 deacetylation by SIRT1 is involved in neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson’s disease

    Y. Wu, Y. Guo, S. Dong, X. Cui, Y. Feng, W. Zhao (Shanghai, People's Republic of China)

    Objective: Our previous study has demonstrated that resveratrol (RV) enhanced clearance of misfolded α-synuclein proteins in cellular models of PD, with the activation of SIRT1…
  • « Previous Page
  • 1
  • …
  • 1600
  • 1601
  • 1602
  • 1603
  • 1604
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley